The Ningbo Key Laboratory of Inhaled Drug Development and Intelligent Delivery is affiliated with the School of Biomedical Engineering at the Eastern Institute of Technology, Ningbo. It aims to build China's first and world-leading innovation and development platform for pulmonary delivery of dry-powder drugs, providing systematic scientific support for breakthroughs in basic research, key technological advances, and clinical translation in the field of inhaled drugs, and serving the development of the biopharmaceutical industry in Ningbo and across China.
The Laboratory conducts pioneering research across the entire chain of inhaled drug development, including customized engineering of micro/nano particles, AI-driven new drug discovery and delivery research, flow channel design and intelligent monitoring technology for inhalation devices, and the construction of novel organoid-based drug evaluation systems. It has established an academic committee led by academicians and spanning multiple disciplines to guide its long-term development, and has initially formed a core research team with an international perspective and a strong emphasis on both research and industrial application, continuously promoting the deep integration of basic research and industrial translation.





